We use cookies to provide you with the best of services and customized features. By continuing to browse this website, you give your informed consent to our Cookie Policy.
Terray Therapeutics has emerged with $60 million in series A funding and a mission to turbocharge drug discovery using artificial intelligence and nanotechnology.
